Martyn Coombs

Chief Executive Officer at ImaginAb, Inc.

Martyn Coombs

Martyn Coombs

Chief Executive Officer at ImaginAb, Inc.

Overview
Career Highlights

Jubilant Draximage, Inc.
Amersham KK
Perkinelmer Japan Co. Ltd.

RelSci Relationships

148

Number of Boards

2

Relationships

Co-Founder at ImaginAb, Inc.

Co-Founder at Cycad Group LLC

Partner at Nextech Invest AG

Executive Chairman, Chief Executive Officer & President at Neurovance, Inc.

Non-Executive Chairman, Chief Executive Officer & Secretary at BioSeek Plc

Chief Financial Officer at Regent Education, Inc.

Professor at University of California - San Francisco

Chief Executive Officer at Mérieux Développement SASU

Professor at Duke University

Head, Canary Center-Cancer Early Detection at Stanford University - School of Medicine

Subscribe to RelSci Professional to see 148 more Relationships
Paths to Martyn Coombs
Potential Connections via
Relationship Science
You
Martyn Coombs
Chief Executive Officer at ImaginAb, Inc.
Education

Warwick Business School (WBS) is the UK’s top provider of finance and business research and education. They have the ambition and the capability to become Europe’s leading university-based business school. Our mission is to publish leading-edge research which has real impact; to produce world-class business leaders; and to provide a lifelong return on investment for students, alumni and partners. As the largest department of the University of Warwick, They offer both excellent facilities and a prestigious reputation to students who come from around 120 countries to learn at undergraduate, masters, MBA, and PhD levels.

Career History
Chief Executive Officer
2017 - Current

ImaginAb, Inc. develops engineered antibody fragments for diagnostic imaging and novel therapeutic applications. It products offer actionable data to facilitate diagnosis of disease, inform better treatment decisions, and monitor response to therapy. The firm also offers a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT, and optical imaging systems. The company was founded by Christian P. Behrenbruch, Tove Olafsen, Anna M. Wu, and Robert E. Reiter in 2007 and is headquartered in Inglewood, CA.

President
Prior - 2017

Part of Jubilant Life Sciences Ltd., Jubilant Draximage, Inc. is a company headquartered in Kirkland, QC, Canada. The firm develops, manufactures and commercializes radiopharmaceuticals products for diagnosis, treatment and monitoring of disease. An excerpt from the company's website reads as follows: Jubilant DraxImage Inc., a subsidiary of Jubilant Life Sciences, develops, manufactures and commercializes radiopharmaceuticals used for the diagnosis and treatment of disease. The company is dedicated to nuclear medicine and serves customers and through them patients, globally, with high quality and reliable products and services. The company is the market leader in North America for I-131 products (diagnosis and treatment of thyroid disorder and cancer), MAA (lung perfusion imaging), DTPA (renal, Brain imaging) and MDP (bone imaging), and also markets other products such as Sestamibi (myocardial perfusion imaging), Gluceptate (brain and renal imaging), and Rubidium-82 Generator (PET Cardiology). The company also has a strong development pipeline of new products.

President, Jubilant Draximage
Prior - 2017

Jubilant Life Sciences Limited, is an integrated Pharmaceutical & Life Sciences company. As India's largest Custom Research and Manufacturing Services (CRAMS) player and a leading Drug Discovery and Development Solutions provider out of India, it is constantly engaged in delivering value to its global customers through innovative technologies, products and services. The Company's strategic focus is to innovate, collaborate and accelerate the process of delivering products to the market for its customers. Today, it is well recognised as a Partner of Choice’ by leading global pharma and Life Sciences companies. The Company through its presence in India, USA, Canada, Europe and China constantly serves its customers spread across 90 countries.

Subscribe now for extended career history
Boards & Committees
Member, Board of Directors
2017 - Current

ImaginAb, Inc. develops engineered antibody fragments for diagnostic imaging and novel therapeutic applications. It products offer actionable data to facilitate diagnosis of disease, inform better treatment decisions, and monitor response to therapy. The firm also offers a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT, and optical imaging systems. The company was founded by Christian P. Behrenbruch, Tove Olafsen, Anna M. Wu, and Robert E. Reiter in 2007 and is headquartered in Inglewood, CA.

President & Executive Director
Prior
Subscribe now to see corporate board memberships for over 7 million people
Subscribe now to see non-profit board memberships for over 7 million people
Subscribe now to see government board memberships for over 7 million people
Transactions
Details Hidden

ImaginAb, Inc. raised money in a private placement transaction